Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 5/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | DRD5 | P21918 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4323244 | 0.85 | DRD1 (0.50) | SLC6A2SLC6A4SLC6A3DRD1DRD5 | |
| SCHEMBL4318796 | 0.85 | DRD1 (0.50) | SLC6A2SLC6A4SLC6A3DRD1DRD5 | |
| SCHEMBL4461630 | 0.78 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3SMN1; SMN2 | |
| SCHEMBL4458919 | 0.77 | SLC6A2 (0.48) | SLC6A2SLC6A4SLC6A3SMN1; SMN2 | |
| SCHEMBL4323108 | 0.77 | SLC6A2 (0.48) | SLC6A2SLC6A4SLC6A3SMN1; SMN2 | |
| SCHEMBL4333706 | 0.74 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4460770 | 0.72 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4457874 | 0.72 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4456475 | 0.72 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3SMN1; SMN2 | |
| SCHEMBL4472380 | 0.72 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009118765-A2 | NOVEL MONOAMINE RE-UPTAKE INHIBITOR | PANACEA BIOTEC LIMITED (GB) | 2009-10-01 | — | — | WO | disclosed |